More Information
Clinical Laboratory
Subscribe

Subscribe to our mailing list!

Contact Us

Thrombosis Research
2501 North Orange Avenue
Suite #786
Orlando, FL 32804

Phone: (407) 303-2440 (main office)
Phone: (407) 303-2449 (clinical lab)
Fax: (407) 303-2441

Request more information

Invited Review Articles

2008

Amirkhosravi A, Mousa SA, Amaya M, Meyer TV, Davila M, Robson T, Francis JL. Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis (in press).

2007

Amirkhosravi A, Meyer TV, Amaya M, Davila M, Mousa SA, Robson T, Francis JL. The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis. Seminars in Thrombosis and Hemostasis 7: 643-652, 2007

Drexler, A.  Managing the Patient with HIT. Nursing2007 Critical Care, 2(6): 18-26, 2007.

2006

Francis JL. The Platelet Function Analyzer (PFA)-100. In: Platelets 2nd edition. Ed: Michelson AD. Academic Press, 2006.

Francis JL. The Clinical Presentation, Temporal Relationship, and Outcome in Thirty three patients with Type II Heparin-induced Thrombocytopenia Post-Cardiotomy (Invited Commentary). Annals of Thoracic Surgery 82: 26-27, 2006.

Francis JL and Drexler A. Striking Back at Heparin-induced Thrombocytopenia. Nursing 2006, 36: Suppl. Cardiac: 12-15, 2006.

2005

Amirkhosravi A, Siddiqui F, Ahmad, S and Francis JL. Hemostasis and Angiogenesis In: New Angiogenesis Research, Zubar RV (Ed.) 2005.

Francis JL and Drexler A. Striking Back at Heparin-Induced Thrombocytopenia. Nursing 2005 35: 48-51, 2005.

Francis JL. Detection and Significance of Heparin-Platelet Factor 4 Antibodies. Seminars in Hematology 42: S9-S14, 2005.

 

2004

Warkentin TE, Francis JL and Bartholomew JR. Bivalirudin: A promising strategy for the prevention and treatment of heparin-induced thrombocytopenia. Clinical Roundtable Monograph. Clinical Advances in Hematology and Oncology, January 2004

Francis JL. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Seminars in Hemostasis and Thrombosis 30: 359-368, 2004. Abstract and Related Articles.

Niccolai CS, Hicks RW, Oertel L and Francis JL. Unfractionated heparin: Focus on a high-alert drug. Pharmacotherapy 24: 146S-155S, 2004. Abstract and Related Articles.

Francis, JL and Groce, J.B., III. Challenges in variation and responsiveness of unfractionated heparin. Pharmacotherapy 24: 108S-119S, 2004. Abstract and Related Articles.

Bussey H and Francis JL. Heparin overview and issues. Pharmacotherapy 24: 103S-107S, 2004. Abstract and Related Articles.

2002

Francis JL and Amirkhosravi A. Effects of modulating hemostasis on experimental metastasis. Thrombosis in Oncology. Physicians’ Education Resource 5, No. 2, 5-8, 2002.

Francis JL. The Platelet Function Analyzer (PFA)-100. In: Platelets. Ed: Michelson AD. Academic Press 2002.

Francis JL and Amirkhosravi A. Effect of antihemostatic agents on experimental tumor dissemination. Seminars in Thrombosis and Hemostasis 28: 29-38, 2002. Abstract and Related Articles.

1998 and earlier

Francis JL, Biggerstaff JP and Amirkhosravi A. Hemostasis and Malignancy. Seminars in Thrombosis and Hemostasis 24: 93-109, 1998. Abstract and Related Articles.

Francis JL. Blood Coagulation and Cancer: From Trousseau’s Syndrome to Angiogenesis. Thrombosis in Oncology. Physicians’ Education Resource 1: 6-10, 1998.

Francis JL. Laboratory Investigation of Hypercoagulability. Seminars in Thrombosis and Hemostasis 24: 111-126, 1998. Abstract and Related Articles.

Francis JL, Roath OS. Haemostatic Abnormalities in Patients with Cancer. In: Supportive Care of the Cancer Patient. Sweetenham JW and Williams CJ (eds): Edward Arnold, pp. 258-278, 1997.

Francis JL. Consumptive Coagulopathies. In: Hematology. A Problem Solving Approach. Gross S and Roath S (eds): Williams & Wilkins, Baltimore, pp 599-611, 1996.

Francis JL. Thromboembolic States. In: Hematology. A Problem Solving Approach. Gross S and Roath S (eds): Williams & Wilkins, Baltimore, pp 613-625, 1996.